Lexicon Pharmaceuticals, Inc.
LXRX
$0.53
-$0.0019-0.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -200.40M | -216.39M | -202.11M | -193.58M | -177.12M |
| Total Depreciation and Amortization | 534.00K | 556.00K | 581.00K | 586.00K | 554.00K |
| Total Amortization of Deferred Charges | 1.85M | 2.06M | 2.28M | 2.03M | 1.77M |
| Total Other Non-Cash Items | 5.01M | 7.75M | 7.06M | 10.90M | 10.24M |
| Change in Net Operating Assets | 14.24M | -1.81M | -3.65M | -5.34M | 2.66M |
| Cash from Operations | -178.78M | -207.84M | -195.84M | -185.41M | -161.90M |
| Capital Expenditure | -1.03M | -557.00K | -333.00K | -222.00K | -470.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.35M | -16.62M | -109.64M | -172.04M | -49.47M |
| Cash from Investing | -15.38M | -17.18M | -109.98M | -172.26M | -49.94M |
| Total Debt Issued | -- | -1.00K | 0.00 | 49.96M | 49.96M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 89.00K | 89.00K | 89.00K | 139.12M | 139.03M |
| Repurchase of Common Stock | -1.76M | -1.73M | -1.94M | -1.94M | -1.04M |
| Issuance of Preferred Stock | 241.43M | 241.43M | 241.43M | 241.43M | -- |
| Repurchase of Preferred Stock | -103.00K | -25.00K | -15.00K | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.31M | -1.31M | -400.00K | -400.00K | -- |
| Cash from Financing | 238.35M | 238.45M | 239.16M | 428.17M | 187.96M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 44.19M | 13.44M | -66.65M | 70.49M | -23.88M |